A small percentage of patients with hepatitis C receive triple therapy with boceprevir or telaprevir

Emerson Y. Chen, Seth N. Sclair, Frank Czul, Betty Apica, Perry Dubin, Paul Martin, William M. Lee

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'A small percentage of patients with hepatitis C receive triple therapy with boceprevir or telaprevir'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science